Dr Sven Kili, MD

Partner at Saisei Ventures

Speaker

Dr. Sven Kili is a respected KOL in healthcare and biotechnology, boasting over 20 years ofexperience. He began as a surgeon in the NHS, where he gained valuable insights into patientcare. Transitioning to Cell and Gene Therapies (CGT), Sven played key roles in getting key CGTproducts approved and into the market. With expertise across all stages of CGT development,he has led teams in both big companies and startups.

Sven is a partner at Saisei Ventures, a boutique therapeutic investment firm focussed ongrowing Japanese technologies. He also heads his consulting firm, Sven Kili Consulting, oNeringstrategic guidance to organizations in the biotech and healthcare sectors while also serving asthe Chief Development ONicer for CCRM (Centre for Commercialization of RegenerativeMedicine) and OmniaBio.

Sven actively contributes to industry boards and committees, including the BIA CGTAC,Innovation Hubs for Gene Therapy, ISCT, and ARM. Sven holds a visiting chair at UCL, where heheads the steering committee for a post-grad degree in Cell & Gene Therapy manufacturing andcommercialisation. His dedication to advancing regenerative medicine and CGT is reflected inhis multifaceted roles and ongoing eNorts to shape the future of healthcare through innovationand strategic collaboration.